Bayer is scrambling to get its hands on nearly 1,000 vials of one of its top-selling drugs after a labeling mishap led to them being filled with the wrong hemophilia medicines.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,